Testing effectiveness (Phase 2)Study completedNCT01306942
What this trial is testing
Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC Patients
Who this might be right for
Metastatic Breast Cancer
Spanish Breast Cancer Research Group 37